APLM
Apollomics, Inc.
Price Chart
Latest Quote
$14.00
+0.00 (+0.00%)
Current Price
| Previous Close | $14.00 |
| Open | $14.79 |
| Day High | $14.79 |
| Day Low | $13.59 |
| Volume | 19,045 |
Stock Information
| Shares Outstanding | 2.20M |
| Total Debt | $643K |
| Cash Equivalents | $3.28M |
| Revenue | $8.84M |
| Net Income | $-10.94M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $30.74M |
| EPS (TTM) | $-7.57 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $28.11M |
| Sales | $8.84M |
| Income | $-10.94M |
| Book/sh | $-1.49 |
| Cash/sh | $1.49 |
| Employees | 14 |
Financial Ratios
| Quick Ratio | 0.91 |
| Current Ratio | 0.96 |
Returns & Margins
| ROA | -57.61% |
| ROE | -1305.37% |
| Gross Margin | 100.00% |
| Operating Margin | 431.87% |
| Profit Margin | -123.72% |
Ownership
| Insider Ownership | 53.32% |
| Institutional Ownership | 0.03% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -21.54 |
| P/S | 3.48 |
| P/B | -9.43 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $14.23 |
| SMA50 | $14.50 |
| SMA200 | $16.62 |
| RSI | 35.79 |
| ATR | 1.0749 |
| Shares Float | 1.26M |
| Short Float | 0.29% |
| Short Ratio | 0.62 |
| Volatility | 1.53 |
| Rel Volume | 2.02 |
Performance History
| Week | -1.06% |
| Month | -8.14% |
| Quarter | -30.21% |
| 6 Months | +1.16% |
| YTD | -27.46% |
| Year | +115.38% |
| 3 Years | -96.54% |
| 10 Years | -98.59% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $14.00 | 19,100 |
| 2026-06-04 | $14.00 | 6,100 |
| 2026-06-03 | $13.92 | 8,500 |
| 2026-06-02 | $14.20 | 8,300 |
| 2026-06-01 | $14.33 | 1,700 |
| 2026-05-29 | $14.15 | 21,200 |
| 2026-05-28 | $14.06 | 6,800 |
| 2026-05-27 | $13.94 | 24,200 |
| 2026-05-26 | $14.09 | 1,300 |
| 2026-05-22 | $14.09 | 7,700 |
| 2026-05-21 | $14.31 | 20,600 |
| 2026-05-20 | $13.52 | 1,100 |
| 2026-05-19 | $14.20 | 15,800 |
| 2026-05-18 | $15.00 | 0 |
| 2026-05-15 | $15.00 | 12,500 |
| 2026-05-14 | $13.60 | 12,000 |
| 2026-05-13 | $13.53 | 2,300 |
| 2026-05-12 | $14.65 | 16,000 |
| 2026-05-11 | $14.65 | 2,800 |
| 2026-05-08 | $15.45 | 1,100 |
| 2026-05-07 | $15.90 | 4,300 |
| 2026-05-06 | $15.24 | 3,200 |
About Apollomics, Inc.
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; and APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial for cancer treatment. It also develops immuno-oncology products, such as APL-501, an anti-PD-1 antibody product candidate, which is in phase 1 clinical trial for the treatment of advanced or relapsed/refractory solid tumors; APL-502, an anti-PD-L1 antibody product candidate for the treatment of tumors; APL-810, a novel, rationally designed, ACCI recombinant vaccine for the treatment of gastrin immunogen; and APL-801, a CD40 and PD-L1 antibody product candidate for the treatment of tumors. The company was founded in 2015 and is based in Foster City, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on APLM.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $8,500,000 | $0 | $0 | $0 |
| Operating Revenue | $8,500,000 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $65,000 | $179,000 | $150,000 | $93,000 |
| Total Expenses | $17,694,000 | $42,033,000 | $54,370,000 | $44,388,000 |
| Other Income Expense | $-1,829,000 | $-11,867,000 | $-118,824,000 | $-196,760,000 |
| Other Non Operating Income Expenses | $29,000 | $790,000 | $-120,836,000 | $-196,254,000 |
| Net Non Operating Interest Income Expense | $87,000 | $301,000 | $603,000 | $338,000 |
| Interest Expense Non Operating | $65,000 | $179,000 | $150,000 | $93,000 |
| Operating Expense | $17,694,000 | $42,033,000 | $54,370,000 | $44,388,000 |
| Other Operating Expenses | $-279,000 | $-301,000 | $-464,000 | $-1,016,000 |
| General And Administrative Expense | $12,442,000 | $17,768,000 | $20,641,000 | $9,947,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Net Interest Income | $87,000 | $301,000 | $603,000 | $338,000 |
| Interest Income | $152,000 | $480,000 | $753,000 | $431,000 |
| Normalized Income | $-9,471,180 | $-43,858,970 | $-174,190,480 | $-240,411,260 |
| Net Income From Continuing And Discontinued Operation | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Net Income Common Stockholders | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Net Income | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Net Income Including Noncontrolling Interests | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Net Income Continuous Operations | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Pretax Income | $-10,936,000 | $-53,599,000 | $-172,591,000 | $-240,810,000 |
| Special Income Charges | $-1,717,000 | $-13,000,000 | $0 | $0 |
| Interest Income Non Operating | $152,000 | $480,000 | $753,000 | $431,000 |
| Operating Income | $-9,194,000 | $-42,033,000 | $-54,370,000 | $-44,388,000 |
| Per Share | ||||
| Diluted EPS | - | $-52.80 | $-231.99 | $-2.99 |
| Basic EPS | - | $-52.80 | $-231.99 | $-2.99 |
| Other | ||||
| Tax Effect Of Unusual Items | $-390,180 | $-2,657,970 | $422,520 | $-106,260 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,758,000 | $-40,402,000 | $-173,784,000 | $-239,436,000 |
| Total Unusual Items | $-1,858,000 | $-12,657,000 | $2,012,000 | $-506,000 |
| Total Unusual Items Excluding Goodwill | $-1,858,000 | $-12,657,000 | $2,012,000 | $-506,000 |
| Reconciled Depreciation | $255,000 | $361,000 | $669,000 | $775,000 |
| EBITDA (Bullshit earnings) | $-10,616,000 | $-53,059,000 | $-171,772,000 | $-239,942,000 |
| EBIT | $-10,871,000 | $-53,420,000 | $-172,441,000 | $-240,717,000 |
| Diluted NI Availto Com Stockholders | $-10,939,000 | $-53,858,000 | $-172,601,000 | $-240,811,000 |
| Tax Provision | $3,000 | $259,000 | $10,000 | $1,000 |
| Impairment Of Capital Assets | $1,717,000 | $13,000,000 | $0 | $0 |
| Gain On Sale Of Security | $-141,000 | $343,000 | $2,012,000 | $-506,000 |
| Research And Development | $5,531,000 | $24,566,000 | $34,193,000 | $35,457,000 |
| Selling General And Administration | $12,442,000 | $17,768,000 | $20,641,000 | $9,947,000 |
| Other Gand A | $12,442,000 | $17,768,000 | $20,641,000 | $9,947,000 |
| Diluted Average Shares | - | $1,020,000 | $744,000 | $80,447,260 |
| Basic Average Shares | - | $1,020,000 | $744,000 | $80,447,260 |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,188,000 | $3,127,000 | $26,477,000 | $-462,898,000 |
| Total Assets | $6,714,000 | $13,098,000 | $55,387,000 | $76,475,000 |
| Total Non Current Assets | $663,000 | $2,831,000 | $15,462,000 | $20,685,000 |
| Non Current Prepaid Assets | $83,000 | $75,000 | $119,000 | $124,000 |
| Goodwill And Other Intangible Assets | $0 | $1,737,000 | $14,757,000 | $14,778,000 |
| Current Assets | $6,051,000 | $10,267,000 | $39,925,000 | $55,790,000 |
| Prepaid Assets | $285,000 | $374,000 | $1,642,000 | $629,000 |
| Receivables | $2,490,000 | $127,000 | $466,000 | $547,000 |
| Taxes Receivable | $185,000 | $127,000 | $466,000 | $547,000 |
| Accounts Receivable | $2,305,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $3,276,000 | $9,766,000 | $37,817,000 | $54,614,000 |
| Cash And Cash Equivalents | $3,276,000 | $9,766,000 | $32,056,000 | $32,675,000 |
| Other Intangible Assets | - | $1,737,000 | $14,757,000 | $14,778,000 |
| Current Deferred Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $643,000 | $966,000 | $4,661,000 | $991,000 |
| Long Term Debt And Capital Lease Obligation | $434,000 | $733,000 | $267,000 | $377,000 |
| Current Debt And Capital Lease Obligation | $209,000 | $233,000 | $4,394,000 | $614,000 |
| Current Debt | - | - | $4,236,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,902,000 | $8,234,000 | $14,153,000 | $524,595,000 |
| Total Non Current Liabilities Net Minority Interest | $3,576,000 | $835,000 | $597,000 | $512,238,000 |
| Other Non Current Liabilities | $3,018,000 | - | - | $511,861,000 |
| Derivative Product Liabilities | $124,000 | $102,000 | $330,000 | $0 |
| Current Liabilities | $6,326,000 | $7,399,000 | $13,556,000 | $12,357,000 |
| Payables And Accrued Expenses | $6,117,000 | $7,166,000 | $9,162,000 | $11,675,000 |
| Payables | $1,786,000 | $1,248,000 | $5,971,000 | $7,538,000 |
| Other Payable | $1,786,000 | $1,248,000 | $5,971,000 | $7,538,000 |
| Other Current Liabilities | - | - | - | $68,000 |
| Current Deferred Liabilities | - | - | - | $1,000,000 |
| Total Tax Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-3,188,000 | $4,864,000 | $41,234,000 | $-448,120,000 |
| Total Equity Gross Minority Interest | $-3,188,000 | $4,864,000 | $41,234,000 | $-448,120,000 |
| Stockholders Equity | $-3,188,000 | $4,864,000 | $41,234,000 | $-448,120,000 |
| Other Equity Interest | $34,734,000 | $35,713,000 | $23,281,000 | $10,830,000 |
| Gains Losses Not Affecting Retained Earnings | $3,435,000 | $3,435,000 | $3,435,000 | $3,398,000 |
| Other Equity Adjustments | $3,435,000 | $3,435,000 | $3,435,000 | $3,398,000 |
| Retained Earnings | $-711,762,000 | $-700,823,000 | $-646,965,000 | $-474,600,000 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $511,861,000 |
| Other | ||||
| Ordinary Shares Number | $2,147,105 | $1,102,792 | $894,957 | $80,447,260 |
| Share Issued | $2,147,105 | $1,102,792 | $894,957 | $80,447,260 |
| Tangible Book Value | $-3,188,000 | $3,127,000 | $26,477,000 | $-462,898,000 |
| Invested Capital | $-3,188,000 | $4,864,000 | $45,470,000 | $-448,120,000 |
| Working Capital | $-275,000 | $2,868,000 | $26,369,000 | $43,433,000 |
| Capital Lease Obligations | $643,000 | $966,000 | $425,000 | $991,000 |
| Total Capitalization | $-3,188,000 | $4,864,000 | $41,234,000 | $-448,120,000 |
| Additional Paid In Capital | $670,384,000 | $666,528,000 | $661,474,000 | $12,279,000 |
| Capital Stock | $21,000 | $11,000 | $9,000 | $41,000 |
| Common Stock | $21,000 | $11,000 | $9,000 | $41,000 |
| Long Term Capital Lease Obligation | $434,000 | $733,000 | $267,000 | $377,000 |
| Current Capital Lease Obligation | $209,000 | $233,000 | $158,000 | $614,000 |
| Current Accrued Expenses | $4,331,000 | $5,918,000 | $3,191,000 | $4,137,000 |
| Net PPE | $580,000 | $1,019,000 | $586,000 | $1,476,000 |
| Accumulated Depreciation | $-507,000 | $-490,000 | $-2,578,000 | $-2,376,000 |
| Gross PPE | $1,087,000 | $1,509,000 | $3,164,000 | $3,852,000 |
| Leases | $88,000 | $124,000 | $135,000 | $135,000 |
| Machinery Furniture Equipment | $88,000 | $403,000 | $455,000 | $852,000 |
| Buildings And Improvements | $911,000 | $982,000 | $2,574,000 | $2,865,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Stock | - | $0 | $0 | $68,000 |
| Line Of Credit | - | $0 | $4,236,000 | $0 |
| Other Short Term Investments | - | $0 | $5,761,000 | $21,939,000 |
| Investments And Advances | - | - | $0 | $4,307,000 |
| Other Investments | - | - | $0 | $4,307,000 |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-10,369,000 | $-28,767,000 | $-43,215,000 | $-43,191,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,369,000 | $-28,743,000 | $-43,209,000 | $-42,824,000 |
| Cash Flow From Continuing Operating Activities | $-10,369,000 | $-28,743,000 | $-43,209,000 | $-42,824,000 |
| Operating Gains Losses | $15,000 | $18,000 | $-53,000 | $-1,900,000 |
| Investing Activities | ||||
| Investing Cash Flow | $218,000 | $5,983,000 | $21,365,000 | $29,053,000 |
| Cash Flow From Continuing Investing Activities | $218,000 | $5,983,000 | $21,365,000 | $29,053,000 |
| Net Other Investing Changes | $18,000 | $44,000 | $5,000 | $-11,000 |
| Capital Expenditure | - | $-24,000 | $-6,000 | $-367,000 |
| Financing Activities | ||||
| Financing Cash Flow | $3,676,000 | $468,000 | $21,225,000 | $-294,000 |
| Cash Flow From Continuing Financing Activities | $3,676,000 | $468,000 | $21,225,000 | $-294,000 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Other Financing Charges | - | - | $-2,779,000 | - |
| Issuance Of Capital Stock | - | - | - | $392,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $392,000 |
| Common Stock Issuance | - | - | - | $392,000 |
| Other | ||||
| Repayment Of Debt | $-125,000 | $-5,090,000 | $-444,000 | $-593,000 |
| Issuance Of Debt | $3,859,000 | $5,751,000 | $24,485,000 | $0 |
| End Cash Position | $3,276,000 | $9,766,000 | $32,056,000 | $32,675,000 |
| Beginning Cash Position | $9,766,000 | $32,056,000 | $32,675,000 | $46,740,000 |
| Effect Of Exchange Rate Changes | $-15,000 | $2,000 | $0 | $0 |
| Changes In Cash | $-6,475,000 | $-22,292,000 | $-619,000 | $-14,065,000 |
| Interest Paid Cff | $-65,000 | $-193,000 | $-122,000 | $-93,000 |
| Proceeds From Stock Option Exercised | $7,000 | $0 | $85,000 | $392,000 |
| Net Issuance Payments Of Debt | $3,734,000 | $661,000 | $24,041,000 | $-593,000 |
| Net Short Term Debt Issuance | $0 | $-4,218,000 | $4,236,000 | $0 |
| Short Term Debt Payments | $0 | $-4,920,000 | $0 | $0 |
| Short Term Debt Issuance | $0 | $702,000 | $4,236,000 | $0 |
| Net Long Term Debt Issuance | $3,734,000 | $4,879,000 | $19,805,000 | $-593,000 |
| Long Term Debt Payments | $-125,000 | $-170,000 | $-444,000 | $-593,000 |
| Long Term Debt Issuance | $3,859,000 | $5,049,000 | $20,249,000 | $0 |
| Interest Received Cfi | $152,000 | $198,000 | $821,000 | $431,000 |
| Net Investment Purchase And Sale | $0 | $5,761,000 | $20,487,000 | $29,000,000 |
| Sale Of Investment | $0 | $5,761,000 | $20,487,000 | $29,000,000 |
| Net PPE Purchase And Sale | $48,000 | $-20,000 | $52,000 | $-367,000 |
| Sale Of PPE | $48,000 | $4,000 | $58,000 | $0 |
| Purchase Of PPE | $0 | $-24,000 | $-6,000 | $-367,000 |
| Taxes Refund Paid | $-3,000 | $-259,000 | $-10,000 | $56,000 |
| Change In Working Capital | $-380,000 | $1,037,000 | $-3,567,000 | $6,488,000 |
| Change In Payables And Accrued Expense | $1,903,000 | $-571,000 | $-2,635,000 | $2,837,000 |
| Change In Payable | $1,903,000 | $-571,000 | $-2,635,000 | $2,837,000 |
| Change In Prepaid Assets | $-2,283,000 | $1,608,000 | $-932,000 | $3,651,000 |
| Other Non Cash Items | $-80,000 | $-5,000 | $44,825,000 | $-338,000 |
| Stock Based Compensation | $-979,000 | $10,926,000 | $12,685,000 | $3,582,000 |
| Unrealized Gain Loss On Investment Securities | $22,000 | $-222,000 | $74,833,000 | $189,323,000 |
| Asset Impairment Charge | $1,717,000 | $13,000,000 | $0 | $0 |
| Depreciation Amortization Depletion | $255,000 | $361,000 | $669,000 | $775,000 |
| Depreciation And Amortization | $255,000 | $361,000 | $669,000 | $775,000 |
| Amortization Cash Flow | $20,000 | $20,000 | $20,000 | $20,000 |
| Amortization Of Intangibles | $20,000 | $20,000 | $20,000 | $20,000 |
| Depreciation | $235,000 | $341,000 | $649,000 | $755,000 |
| Net Foreign Currency Exchange Gain Loss | $0 | $0 | $-279,000 | $-1,900,000 |
| Gain Loss On Sale Of PPE | $15,000 | $18,000 | $188,000 | $0 |
| Net Income From Continuing Operations | $-10,936,000 | $-53,599,000 | $-172,591,000 | $-240,810,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Intangibles | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | $38,000 | - |
| Purchase Of Investment | - | - | - | $0 |
Fetched: 2026-06-02